Chemoinformaics analysis of o-Tolualdehyde O-pentafluorophenylmethyl-oxime
| Molecular Weight | 315.241 | nRot | 4 |
| Heavy Atom Molecular Weight | 305.161 | nRig | 13 |
| Exact Molecular Weight | 315.068 | nRing | 2 |
| Solubility: LogS | -7.105 | nHRing | 0 |
| Solubility: LogP | 5.437 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 12 |
| nHA | 2 | APOL | 36.4049 |
| nHD | 0 | BPOL | 17.3331 |
| QED | 0.272 |
| Synth | 2.586 |
| Natural Product Likeliness | -0.869 |
| NR-PPAR-gamma | 0.021 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.105 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.517 |
| MDCK | 0.000111361 |
| BBB | 0.039 |
| PPB | 0.990901 |
| VDSS | 0.928 |
| FU | 0.0101764 |
| CYP1A2-inh | 0.46 |
| CYP1A2-sub | 0.906 |
| CYP2c19-inh | 0.953 |
| CYP2c19-sub | 0.301 |
| CYP2c9-inh | 0.921 |
| CYP2c9-sub | 0.979 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.521 |
| CYP3a4-inh | 0.373 |
| CYP3a4-sub | 0.223 |
| CL | 4.679 |
| T12 | 0.05 |
| hERG | 0.003 |
| Ames | 0.678 |
| ROA | 0.264 |
| SkinSen | 0.384 |
| Carcinogencity | 0.644 |
| EI | 0.972 |
| Respiratory | 0.884 |
| NR-Aromatase | 0.102 |
| Antiviral | Yes |
| Prediction | 0.815941 |